HOME > TOP STORIES
TOP STORIES
-
REGULATORY Amended PMD Law Set for 3-Step Enforcement, 1st Execution Eyed Next Autumn
November 28, 2019
-
BUSINESS Big 4 Drug Wholesalers Raided on Bid-Rigging Charges
November 28, 2019
-
REGULATORY Japan’s First Biosimilars of Avastin, Nesp, Forteo Receive Listing
November 27, 2019
-
BUSINESS Asahi Kasei to Buy Veloxis for 143.2 Billion Yen, Eyes US Transplant Market
November 26, 2019
-
REGULATORY MOF Panel Leery of Pricey Drugs for Huge Patient Population: FY2020 Budget Recommendation
November 26, 2019
-
REGULATORY Xolair’s Pollen Allergy Nod Delayed as Novartis Says It Needs More Time to Prepare for Launch
November 25, 2019
-
REGULATORY MHLW Wants to Ease Unfairness Concerns by Adding New Innovation Gauge to PMP Company Criteria
November 25, 2019
-
COMMENTARY Unison Capital Shows Rising Presence with Kyowa Deal, PE Fund Potential Catalyst for Industry Shakeup?
November 22, 2019
-
BUSINESS Evenity Debut, Copycat Entries Set to Jolt Power Map of Japan Osteoporosis Market
November 21, 2019
-
REGULATORY MHLW to Propose “Special Rule” for Indication Change Re-Pricing
November 21, 2019
-
BUSINESS Sumitomo Dainippon to Solely Promote Novartis Diabetes Meds from January
November 20, 2019
-
BUSINESS Mitsubishi Chemical to Fully Own Mitsubishi Tanabe to Solidify Healthcare Platform
November 19, 2019
-
ORGANIZATION RIKEN Develops Supercomputer for Molecular Dynamics Simulation, Will Be Made Available to Drug Makers for Drug Discovery Use
November 19, 2019
-
COMMENTARY Finance Officials, Payers Grow Jittery as Xolair’s Pollen Allergy Nod Looms
November 18, 2019
-
REGULATORY Will Japan Reinstate Sakigake Status for Aducanumab? Many See It Unlikely
November 15, 2019
-
BUSINESS Big 4 Japan Wholesalers Eke Out 1% Operating Margins: Jiho Tally
November 14, 2019
-
REGULATORY Keytruda to Get 17.5% Price Cut in February
November 13, 2019
-
REGULATORY Keytruda Faces Price Slash on Better-than-Expected Sales
November 12, 2019
-
REGULATORY Japan to Use September 2019 Market Price Data for 2020 Revisions, April 2018 NHI Prices as Baseline
November 11, 2019
-
REGULATORY Opposition Party Set to Compile HPV Vaccine Proposal by Year-End
November 8, 2019
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
